Literature DB >> 12881202

Mu-opioid receptor agonist effects on medullary respiratory neurons in the cat: evidence for involvement in certain types of ventilatory disturbances.

Peter M Lalley1.   

Abstract

Mu-opioid receptor agonists depress tidal volume, decrease chest wall compliance, and increase upper airway resistance. In this study, potential neuronal sites and mechanisms responsible for the disturbances were investigated, dose-response relationships were established, and it was determined whether general anesthesia plays a role. Effects of micro-opioid agonists on membrane properties and discharges of respiratory bulbospinal, vagal, and propriobulbar neurons and phrenic nerve activity were measured in pentobarbital-anesthetized and unanesthetized decerebrate cats. In all types of respiratory neurons tested, threshold intravenous doses of the micro-opioid agonist fentanyl slowed discharge frequency and prolonged duration without altering peak discharge intensity. Larger doses postsynaptically depressed discharges of inspiratory bulbospinal and inspiratory propriobulbar neurons that might account for depression of tidal volume. Iontophoresis of the micro-opioid agonist DAMGO also depressed the intensity of inspiratory bulbospinal neuron discharges. Fentanyl given intravenously prolonged discharges leading to tonic firing of bulbospinal expiratory neurons in association with reduced hyperpolarizing synaptic drive potentials, perhaps explaining decreased inspiratory phase chest wall compliance. Lowest effective doses of fentanyl had similar effects on vagal postinspiratory (laryngeal adductor) motoneurons, whereas in vagal laryngeal abductor and pharyngeal constrictor motoneurons, depression of depolarizing synaptic drive potentials led to sparse, very-low-frequency discharges. Such effects on three types of vagal motoneurons might explain tonic vocal fold closure and pharyngeal obstruction of airflow. Measurements of membrane potential and input resistance suggest the effects on bulbospinal Aug-E neurons and vagal motoneurons are mediated presynaptically. Opioid effects on the respiratory neurons were similar in anesthetized and decerebrate preparations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12881202     DOI: 10.1152/ajpregu.00199.2003

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  41 in total

1.  Role of the dorsomedial medulla in suppression of cough by codeine in cats.

Authors:  Ivan Poliacek; Michal Simera; Marcel Veternik; Zuzana Kotmanova; Donald C Bolser; Peter Machac; Jan Jakus
Journal:  Respir Physiol Neurobiol       Date:  2017-08-01       Impact factor: 1.931

2.  Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle activity in vivo.

Authors:  Mohammad Hajiha; Marq-André DuBord; Hattie Liu; Richard L Horner
Journal:  J Physiol       Date:  2009-04-29       Impact factor: 5.182

Review 3.  SEDASYS(®), airway, oxygenation, and ventilation: anticipating and managing the challenges.

Authors:  Basavana Gouda Goudra; Preet Mohinder Singh; Vinay Chandrasekhara
Journal:  Dig Dis Sci       Date:  2014-01-08       Impact factor: 3.199

4.  Opioid-induced suppression of genioglossal muscle activity: is it clinically important?

Authors:  David P White
Journal:  J Physiol       Date:  2009-07-15       Impact factor: 5.182

5.  [Intrathecal morphine in orthopaedic surgery patients. Optimised dose in patients receiving dipyrone].

Authors:  M Gehling; M Tryba
Journal:  Anaesthesist       Date:  2008-04       Impact factor: 1.041

6.  Expanding access to naloxone in the United States.

Authors:  Suzanne Doyon; Steven E Aks; Scott Schaeffer
Journal:  J Med Toxicol       Date:  2014-12

7.  Opioid receptors on bulbospinal respiratory neurons are not activated during neuronal depression by clinically relevant opioid concentrations.

Authors:  Astrid G Stucke; Edward J Zuperku; Antonio Sanchez; Mislav Tonkovic-Capin; Viseslav Tonkovic-Capin; Sanda Mustapic; Eckehard A Stuth
Journal:  J Neurophysiol       Date:  2008-09-24       Impact factor: 2.714

8.  Clinically relevant infusion rates of mu-opioid agonist remifentanil cause bradypnea in decerebrate dogs but not via direct effects in the pre-Bötzinger complex region.

Authors:  Sanda Mustapic; Tomislav Radocaj; Antonio Sanchez; Zoran Dogas; Astrid G Stucke; Francis A Hopp; Eckehard A E Stuth; Edward J Zuperku
Journal:  J Neurophysiol       Date:  2009-11-11       Impact factor: 2.714

9.  Excitatory and inhibitory effects of opioid agonists on respiratory motor output produced by isolated brainstems from adult turtles (Trachemys).

Authors:  Stephen M Johnson; Christina M Moris; Michelle E Bartman; Liana M Wiegel
Journal:  Respir Physiol Neurobiol       Date:  2009-10-13       Impact factor: 1.931

10.  Opiate-induced suppression of rat hypoglossal motoneuron activity and its reversal by ampakine therapy.

Authors:  Amanda R Lorier; Gregory D Funk; John J Greer
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.